Post stroke walking dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Complies with the "Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage (2019)" formulated by the Neurology Branch of the Chinese Medical Association, and refers to the diagnostic criteria of the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023" formulated by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association, confirmed by head CT or MRI, and with a disease duration of = 17 or MoCA >= 24; 6. Be able to follow clinical treatment plans and sign informed consent forms for subjects;
Exclusion criteria
Exclusion criteria: 1. Individuals with walking dysfunction prior to stroke; 2. Individuals with visual impairments or partial neglect; 3. Individuals with severe cognitive impairment or post-stroke depression; 4. Individuals with metal implants in their bodies, such as pacemakers and other metal devices; 5. Suffering from serious underlying diseases, such as NYHA heart function level 4 or severe COPD; 6. Participants who participate in other clinical trials during the same period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugle Meyer Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional Independence Assessment Scale (FIM);Magnetic resonance diffusion tensor imaging (DTI) FA value.;Berg Balance Scale;Stand up Walking Test;Holden Walking Function Grading;10 meter Walking Ability Test; | — |
Countries
China
Contacts
Chongqing jiangbei hospital of traditional chinese medicine